Purchase of next generation sequencer
Ended Purchase Order Awarded
- Contract number
- 75D30121P10771
- Awardee
-
Biomedic Science Material Joint Stock Company UEI YSUDESVNQNB7
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $222,945
Award facts
- Contract value 100% obligated
- $222,945.10 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q702 Technical Medical Support
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Vietnam
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order to Biomedic Science Material Joint Stock Company (Biomedic, JSC) for the purchase of a next generation sequencer. The $222,945.10 contract has a completion date of May 21, 2021 and does not utilize any set-aside designations. The place of performance is Vietnam.
Quick answers
Who was awarded contract 75D30121P10771?
75D30121P10771 was awarded to Biomedic Science Material Joint Stock Company by CDC Pittsburgh (Centers for Disease Control and Prevention) on May 21, 2021.
How much is contract 75D30121P10771 worth?
The government has obligated $222,945 on 75D30121P10771.
Was contract 75D30121P10771 competed?
The extent of competition for 75D30121P10771 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award